Generation of a set of genetically modified long QT syndrome induced pluripotent stem cell lines carrying knock-in variants rs120074178 (KCNQ1 c.569G > A; p.Arg190Gln) and rs137854600 (SCN5A c.4865G > A; p.Arg1622Gln) and isogenic control lines

Stem Cell Res. 2025 Sep:87:103755. doi: 10.1016/j.scr.2025.103755. Epub 2025 Jun 18.

Abstract

Long QT syndrome (LQTS) is an inherited channelopathy characterized by life-threatening arrhythmias. LQTS has many subtypes defined by the gene that contains the mutation, including LQT1 (KCNQ1), LQT2 (KCNH2), and LQT3 (SCN5A). Here, we used CRISPR/Cas9 technology to generate five isogenic human induced pluripotent stem cell (iPSC) lines, one line harboring an LQT1 variant rs120074178 (KCNQ1 c.569G > A), two lines harboring an LQT3 variant rs137854600 (SCN5A c.4865G > A), and two derived control lines.

MeSH terms

  • CRISPR-Cas Systems
  • Cell Line
  • Gene Knock-In Techniques
  • Humans
  • Induced Pluripotent Stem Cells* / cytology
  • Induced Pluripotent Stem Cells* / metabolism
  • KCNQ1 Potassium Channel* / genetics
  • Long QT Syndrome* / genetics
  • Long QT Syndrome* / metabolism
  • Long QT Syndrome* / pathology
  • NAV1.5 Voltage-Gated Sodium Channel* / genetics
  • NAV1.5 Voltage-Gated Sodium Channel* / metabolism

Substances

  • NAV1.5 Voltage-Gated Sodium Channel
  • SCN5A protein, human
  • KCNQ1 Potassium Channel
  • KCNQ1 protein, human